Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Southern Medical Journal
|
January 1, 1989
Coronary thrombolysis in rural hospitals
D A Tate, W W Rowe, R J Simpson, et al.
Thrombosis Research
|
August 1, 1996
Variable influence of heparin and contrast agents on platelet function as assessed by the in vitro bleeding time
L G Melton, G J Dehmer, D A Tate, et al.
The American Journal of Cardiology
|
July 30, 1999
Effects of an ionic and nonionic contrast agent on von Willebrand factor assessed during coronary angiography
G J Dehmer, T C Nichols, S Li, et al.
The American Journal of Cardiology
|
May 1, 1997
Absence of human herpesvirus 8 genomes in coronary atherosclerosis in immunocompetent patients
D Ye, T C Nichols, G J Dehmer, et al.
Circulation
|
November 1, 1996
Randomized trial of recombinant platelet factor 4 versus protamine for the reversal of heparin anticoagulation in humans
G J Dehmer, R A Lange, D A Tate, et al.
The American Journal of Cardiology
|
December 15, 1990
Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarction
S D Bleich, T C Nichols, R R Schumacher, et al.
American Heart Journal
|
August 5, 2000
Effect of sex, hemodynamics, body size, and other clinical variables on the corrected thrombolysis in myocardial infarction frame count used as an assessment of coronary blood flow
B A Faile, J A Guzzo, D A Tate, et al.
The American Journal of Cardiology
|
October 29, 2000
Sites of interleukin-6 release in patients with acute coronary syndromes and in patients with congestive heart failure
E N Deliargyris, R J Raymond, T C Theoharides, et al.
The American Journal of Cardiology
|
March 15, 1994
Differences in clot lysis among patients demonstrated in vitro with three thrombolytic agents (tissue-type plasminogen activator, streptokinase and urokinase)
D R Musselman, D A Tate, B J Oberhardt, et al.
Archives of Internal Medicine
|
July 1, 1989
Nonemergent cardiac catheterization and risk-stratified revascularization following thrombolytic therapy for acute myocardial infarction. A critical analysis of therapy in the community setting. University of North Carolina Cardiology Consortium
W W Rowe, R J Simpson, D A Tate, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Southern Medical Journal
|
January 1, 1989
Coronary thrombolysis in rural hospitals
D A Tate, W W Rowe, R J Simpson, et al.
Thrombosis Research
|
August 1, 1996
Variable influence of heparin and contrast agents on platelet function as assessed by the in vitro bleeding time
L G Melton, G J Dehmer, D A Tate, et al.
The American Journal of Cardiology
|
July 30, 1999
Effects of an ionic and nonionic contrast agent on von Willebrand factor assessed during coronary angiography
G J Dehmer, T C Nichols, S Li, et al.
The American Journal of Cardiology
|
May 1, 1997
Absence of human herpesvirus 8 genomes in coronary atherosclerosis in immunocompetent patients
D Ye, T C Nichols, G J Dehmer, et al.
Circulation
|
November 1, 1996
Randomized trial of recombinant platelet factor 4 versus protamine for the reversal of heparin anticoagulation in humans
G J Dehmer, R A Lange, D A Tate, et al.
The American Journal of Cardiology
|
December 15, 1990
Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarction
S D Bleich, T C Nichols, R R Schumacher, et al.
American Heart Journal
|
August 5, 2000
Effect of sex, hemodynamics, body size, and other clinical variables on the corrected thrombolysis in myocardial infarction frame count used as an assessment of coronary blood flow
B A Faile, J A Guzzo, D A Tate, et al.
The American Journal of Cardiology
|
October 29, 2000
Sites of interleukin-6 release in patients with acute coronary syndromes and in patients with congestive heart failure
E N Deliargyris, R J Raymond, T C Theoharides, et al.
The American Journal of Cardiology
|
March 15, 1994
Differences in clot lysis among patients demonstrated in vitro with three thrombolytic agents (tissue-type plasminogen activator, streptokinase and urokinase)
D R Musselman, D A Tate, B J Oberhardt, et al.
Archives of Internal Medicine
|
July 1, 1989
Nonemergent cardiac catheterization and risk-stratified revascularization following thrombolytic therapy for acute myocardial infarction. A critical analysis of therapy in the community setting. University of North Carolina Cardiology Consortium
W W Rowe, R J Simpson, D A Tate, et al.
Page
of 3